08 Apr 2021
Horizon Europe emergency call for urgent research into coronavirus variants opens on 13 April
A budget of €123 million will be mobilised from Horizon Europe for urgent research into coronavirus variants. The Commission launched new calls that complement earlier actions to develop treatments and vaccines by organising and conducting clinical trials to advance the development of promising therapeutics and vaccines against SARS-CoV-2/COVID-19. They will support the development of large scale, COVID-19 cohorts and networks beyond Europe's borders, forging links with European initiatives, as well as reinforce the infrastructures needed to share data, expertise, research resources and expert services among researchers and research organisations.
The projects funded are expected to:
- Establish new and/or build on existing large-scale, multi-centre and regional or multinational cohorts, including beyond Europe's borders, which should rapidly advance the knowledge on SARS-CoV-2 and its emerging variants.
- Further develop promising therapeutic or vaccine candidates against SARS-CoV-2/COVID-19, having already completed preclinical development in clinical studies.
- Support research infrastructures to speed up data sharing and deliver fast research support and expertise, to confront the coronavirus variants and to be ready for future epidemics.
This first emergency funding under Horizon Europe adds to a range of EU-funded research and innovation actions to fight the coronavirus. The calls will open on 13 April and the deadline for submission is 6 May 2021.